ABVC BioPharma, Inc. (ABVC) vs Rein Therapeutics Inc. (RNTX)
A side-by-side comparison of ABVC BioPharma, Inc. and Rein Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABVC
ABVC BioPharma, Inc.
$0.95HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
RNTX
Rein Therapeutics Inc.
$0.82HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — ABVC vs RNTX
growth of $100 · dividends reinvested · last 2yABVC +92.1% (+38.6%/yr)RNTX -61.1% (-37.6%/yr)ABVC compounded faster over this window
ABVC RNTX
ABVC vs RNTX: by the numbers
- •ABVC is the larger company ($25M vs $23M market cap).
Metrics side by side
Valuation
| Metric | ABVC | RNTX |
|---|---|---|
| P/B ratio | 2.40 | 2.25 |
Profitability
| Metric | ABVC | RNTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -76.82% | -487.90% |
| ROIC | -53.34% | -36.89% |
Growth (annualized)
| Metric | ABVC | RNTX |
|---|---|---|
| Total return CAGR (5Y) | -46.33% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.